Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction

Indonesia University40 enrolled

Overview

This study will compare the quality of life between 2 groups, which are group that receive standard moderate acne therapy in addition of lesion extractions, and the second group which only receive standard moderate acne therapy without lesion extractions.

The group allocation will be randomized. Outcome of the study is the quality of life score based on Acne-QoL-INA questionnaire. The study duration is 8 weeks, consists of baseline visit and 2 follow ups at 4th and 8th weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Acne Vulgaris Quality of Life

Interventions

Lesion extractionPROCEDURE

Tretinoin and benzoil peroxide used concurent in both groups as standard therapy

TretinoinDRUG

Tretinoin and benzoil peroxide used concurent in both groups as standard therapy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 59 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Clinically diagnosed as moderate acne vulgaris * Able to read and speak in Indonesia * Indonesian Citizen * Sign the consent form Exclusion Criteria: * Pregnant of breastfeeding women * Acne vulgaris lesion located only outside of face * Experiencing COVID-19 symptoms * Using retinoid acid containing cream or benzoil peroxide in the last 2 weeks * Consume any oral antibiotics in the last 1 month * Injected with intralesional steroid or having acne lesions extracted in the last 2 weeks * Having laser or chemical peeling in the last 1 month

Locations (1)

Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo

Jakarta Pusat, DKI Jakarta, Indonesia

Outcomes

Primary Outcomes

Quality of Life Score

Measured using Acne-QoL-INA questionnaire

Time frame: Every 4 weeks, measured until 8 weeks

Secondary Outcomes

Acne Grading

Lehmann classification of Acne Grading

Time frame: Every 4 weeks, measured until 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.